Skip to main content
News Tag: news
Joan B. Goldberg, MPH, approaches retirement from NRG Oncology and the NSABP Foundation
Read More
Updated Message from NRG Oncology Leadership on COVID-19
Read More
NRG Oncology Winter Holiday Hours
Read More
Adding Peposertib to Radiotherapy for Patients with Advanced Head and Neck Cancer Who are Cisplatin-Ineligible (NRG-HN008)
Read More
Unique Trial Combines Concurrent Immunotherapy and Radiation Therapy to Determine if this Treatment Option Improves Survival Outcomes for Patients with Limited-Stage Small Cell Lung Cancer (NRG-LU005)
Read More
Follow Up Results on First Multicenter Trial to Report Outcomes of Salvage Low Dose Radiotherapy Brachytherapy after External Beam Radiotherapy for Prostate Cancer
Read More
NRG-RTOG 0617 Validates ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Tumor and Normal Tissues in Non-Small Cell Lung Cancer Patients
Read More
NRG Oncology Study on Treatment for Advanced Endometrial Cancer Chosen as ‘Editor’s Choice’ in Journal of Clinical Oncology
Read More
Updated Analysis of NRG-RTOG 9813 Indicates IDH1/2 Mutation Status is Statistically Associated with Better Overall and Progression-free Survival for Patients with Anaplastic Astrocytoma
Read More
Metastasis-Free Survival is a Strong Surrogate Endpoint for Overall Survival over Biochemical Failure for Men Receiving Salvage Radiotherapy for Recurrent Prostate Cancer
Read More